Anlotinib Combined With Chemotherapy for the Treatment of HER2 Negative Advanced Breast Cancer
NCT05334147
·
clinicaltrials.gov ↗
UNKNOWN
Status
315
Enrollment
OTHER
Sponsor class
Conditions
HER2-negative Breast Cancer
Sponsor
The First Affiliated Hospital with Nanjing Medical University